Elekta

Markets showed some disappointment with Q2 miss.

27/11/24 -"Elekta’s Q2 results missed the street’s expectations. Topline growth declined by a mid-single digit percentage as healthy growth in Service was more than offset by weaker Solutions. While ..."

PDF page sample
Pages
62
Language
English
Published on
27/11/24
Download
You may also be interested by these reports :
02/12/24
Even though Philips and Siemens Healthineers share a decent overlap in business areas and Philips has a better report card in terms of stakeholder ...
27/11/24
Elekta’s Q2 results missed the street’s expectations. Topline growth declined by a mid-single digit percentage as healthy growth in Service was more ...
22/11/24
Fresenius reported robust Q3 2024 results, surpassing consensus expectations at revenues (+2%) and at adjusted EBIT by +3%. Anticipating continued ...
21/11/24
Our EPS expectations have been revised down due to the ongoing weakness in Diagnostics owing to Chinese concerns (Made in China initiatives) and the ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO